Wong, Nathan D.

Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: the National Health and Nutrition Examination Survey 2003–2004

Ghandehari, H., Kamal-Bahl, S., & Wong, N. D. (2008) · American Heart Journal

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 180

Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel: This paper is also published in parallel in Archives of Medical Science [Banach M, Rizzo M, Toth PP, et al. Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel. Arch Med Sci 2015; 11(1): 1–23]

Banach, M., Rizzo, M., Toth, P. P., Farnier, M., Davidson, M. H., Al-Rasadi, K., Aronow, W. S., Athyros, V., Djuric, D. M., Ezhov, M. V., et al. (2015) · Expert Opinion on Drug Safety

Lipoproteins and Cardiovascular HealthPharmacovigilance and Adverse Drug Reactions

Cited by 162

Real-world use and modeled impact of glucose-lowering therapies evaluated in recent cardiovascular outcomes trials: An NCDR® Research to Practice project

Arnold, S. V., Inzucchi, S. E., Tang, F., McGuire, D. K., Mehta, S. N., Maddox, T. M., Goyal, A., Sperling, L. S., Einhorn, D., Wong, N. D., et al. (2017) · European Journal of Preventive Cardiology

Diabetes Treatment and ManagementHeart Failure Treatment and Management

Cited by 144

Continuity of care and outpatient management for patients with and at high risk for cardiovascular disease during the COVID-19 pandemic: A scientific statement from the American Society for Preventive Cardiology

Khera, A., Baum, S. J., Gluckman, T. J., Gulati, M., Martin, S. S., Michos, E. D., Navar, A. M., Taub, P. R., Toth, P. P., Virani, S. S., et al. (2020) · American Journal of Preventive Cardiology

COVID-19 and healthcare impactsHealth Promotion and Cardiovascular Prevention

Cited by 143

Molecular Imaging of Matrix Metalloproteinase in Atherosclerotic Lesions

Fujimoto, S., Hartung, D., Ohshima, S., Edwards, D. S., Zhou, J., Yalamanchili, P., Azure, M., Fujimoto, A., Isobe, S., Matsumoto, Y., et al. (2008) · Journal of the American College of Cardiology

Protease and Inhibitor MechanismsCardiac Imaging and Diagnostics

Cited by 133

Risk Factor Differences for Aortic Versus Coronary Calcified Atherosclerosis: The Multiethnic Study of Atherosclerosis

Criqui, M. H., Kamineni, A., Allison, M. A., Ix, J. H., Carr, J. J., Cushman, M., Detrano, R., Post, W., & Wong, N. D. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology

Cardiac Imaging and DiagnosticsCardiovascular Health and Disease Prevention

Cited by 82

Hypertriglyceridemia in statin-treated US adults: the National Health and Nutrition Examination Survey

Fan, W., Philip, S., Granowitz, C., Toth, P. P., & Wong, N. D. (2019) · Journal of Clinical Lipidology

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 67

Artificial intelligence applied to coronary artery calcium scans (AI-CAC) significantly improves cardiovascular events prediction

Naghavi, M., Reeves, A. P., Atlas, K., Zhang, C., Atlas, T., Henschke, C. I., Yankelevitz, D. F., Budoff, M. J., Li, D., Roy, S. K., et al. (2024) · npj Digital Medicine

Cardiac Imaging and DiagnosticsArtificial Intelligence in Healthcare and Education

Cited by 45

Opportunistic Detection of Coronary Artery Calcium on Noncardiac Chest Computed Tomography: An Emerging Tool for Cardiovascular Disease Prevention: A Scientific Statement From the American Heart Association

Foraker, R., Sperling, L., Bratzke, L., Budoff, M., Leppert, M., Razavi, A. C., Rodriguez, F., Shapiro, M. D., Whelton, S., Wong, N. D., et al. (2025) · Circulation

Cardiac Imaging and DiagnosticsHealth Promotion and Cardiovascular Prevention

Cited by 44

Lipid treatment and goal attainment characteristics among persons with atherosclerotic cardiovascular disease in the United States

Klimchak, A. C., Patel, M. Y., Iorga, Ş. R., Kulkarni, N., & Wong, N. D. (2020) · American Journal of Preventive Cardiology

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 43

Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: national Health and Nutrition Examination Survey 2009-2010

Wong, N. D., Chuang, J., Zhao, Y., & Rosenblit, P. D. (2015) · Journal of Clinical Lipidology

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 39

Coronary Artery Calcium Staging to Guide Preventive Interventions

Maron, D. J., Budoff, M. J., Sky, J. C., Bommer, W. J., Epstein, S. D., Fisher, D. A., Stock, E. O., Taylor, A. J., Wong, N. D., & DeMaria, A. N. (2024) · JACC: Advances

Cardiac Imaging and DiagnosticsLipoproteins and Cardiovascular Health

Cited by 32

US Population Eligibility and Estimated Impact of Semaglutide Treatment on Obesity Prevalence and Cardiovascular Disease Events

Wong, N. D., Karthikeyan, H., & Fan, W. (2025) · Cardiovascular Drugs and Therapy

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 26

Use of coronary artery calcium testing to improve coronary heart disease risk assessment in a lung cancer screening population: the Multi-Ethnic Study of Atherosclerosis (MESA)

Garg, P. K., Jorgensen, N. W., McClelland, R. L., Leigh, J. A., Greenland, P., Blaha, M. J., Yoon, A. J., Wong, N. D., Yeboah, J., & Budoff, M. J. (2018) · Journal of Cardiovascular Computed Tomography

Cardiac Imaging and DiagnosticsHealth Promotion and Cardiovascular Prevention

Cited by 26

Rapid achievement of low-density lipoprotein cholesterol goals within 1 month after acute coronary syndrome during combination therapy with rosuvastatin, ezetimibe and bempedoic acid: Initial experience from the LAI-REACT study

Mahajan, K., Puri, R., Duell, P. B., Dutta, D., Yadav, R., Kumar, S., Sharma, J. B., Patel, P., Dsouza, S., Gupta, A., et al. (2024) · Journal of Clinical Lipidology

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 21

Diabetes associated residual atherosclerotic cardiovascular risk in statin-treated patients with prior atherosclerotic cardiovascular disease

Zhao, Y., Xiang, P., Coll, B., López, J. A. G., & Wong, N. D. (2021) · Journal of Diabetes and its Complications

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 19

Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis

Dinu, M., Sofi, F., Lotti, S., Colombini, B., Mattioli, A. V., Catapano, A. L., Casula, M., Baragetti, A., Wong, N. D., Steg, P. G., et al. (2024) · European Journal of Preventive Cardiology

Fatty Acid Research and HealthNutritional Studies and Diet

Cited by 17

Prevalence of United States adults with triglycerides ≥ 135 mg/dL: NHANES 2007–2014

Fan, W., Philip, S., Toth, P. P., Granowitz, C., & Wong, N. D. (2019) · Cardiology Journal

Lipid metabolism and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 6

US Population Eligibility and Estimated Impact of Tirzepatide Treatment on Obesity Prevalence and Cardiovascular Disease Events

Wong, N. D., Karthikeyan, H., & Fan, W. (2025) · Cardiovascular Drugs and Therapy

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 3

Agatston-2.0: A next-generation AI-based coronary calcium quantification approach to improve risk stratification among individuals with zero Agatston scores – Part I

Naghavi, M., Azimi, A., Atlas, K., Reeves, A. P., Zhang, C., Mirjalili, S. R., Mozafarybazargany, M., Jolfayi, A. G., Hashemi, A., Atlas, T., et al. (2026) · American Journal of Preventive Cardiology

Cardiac Imaging and DiagnosticsArtificial Intelligence in Healthcare and Education

Cited by 2